Cargando…
Radial artery as a second conduit gains momentum: The RAPCO trial
In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complet...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272406/ https://www.ncbi.nlm.nih.gov/pubmed/34285901 http://dx.doi.org/10.21542/gcsp.2021.10 |
_version_ | 1783721211463729152 |
---|---|
author | Simry, Walid Afifi, Ahmed |
author_facet | Simry, Walid Afifi, Ahmed |
author_sort | Simry, Walid |
collection | PubMed |
description | In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complete the surgical revascularization. For that purpose, SV remains the most commonly used conduit despite current evidence in favor of arterial grafts. To determine which conduit is best for grafting the second most important coronary artery, Buxton and colleagues have recently published the long term results of their “Radial Artery Patency and Clinical Outcomes (RAPCO)” trial. |
format | Online Article Text |
id | pubmed-8272406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Magdi Yacoub Heart Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-82724062021-07-19 Radial artery as a second conduit gains momentum: The RAPCO trial Simry, Walid Afifi, Ahmed Glob Cardiol Sci Pract Lessons from the Trials In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complete the surgical revascularization. For that purpose, SV remains the most commonly used conduit despite current evidence in favor of arterial grafts. To determine which conduit is best for grafting the second most important coronary artery, Buxton and colleagues have recently published the long term results of their “Radial Artery Patency and Clinical Outcomes (RAPCO)” trial. Magdi Yacoub Heart Foundation 2021-06-30 /pmc/articles/PMC8272406/ /pubmed/34285901 http://dx.doi.org/10.21542/gcsp.2021.10 Text en Copyright ©2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Lessons from the Trials Simry, Walid Afifi, Ahmed Radial artery as a second conduit gains momentum: The RAPCO trial |
title | Radial artery as a second conduit gains momentum: The RAPCO trial |
title_full | Radial artery as a second conduit gains momentum: The RAPCO trial |
title_fullStr | Radial artery as a second conduit gains momentum: The RAPCO trial |
title_full_unstemmed | Radial artery as a second conduit gains momentum: The RAPCO trial |
title_short | Radial artery as a second conduit gains momentum: The RAPCO trial |
title_sort | radial artery as a second conduit gains momentum: the rapco trial |
topic | Lessons from the Trials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272406/ https://www.ncbi.nlm.nih.gov/pubmed/34285901 http://dx.doi.org/10.21542/gcsp.2021.10 |
work_keys_str_mv | AT simrywalid radialarteryasasecondconduitgainsmomentumtherapcotrial AT afifiahmed radialarteryasasecondconduitgainsmomentumtherapcotrial |